Product
JHM03
1 clinical trial
1 indication
Indication
Glabellar LinesClinical trial
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar LinesStatus: Recruiting, Estimated PCD: 2024-10-25